BLTE
Belite Bio·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BLTE Filings
Filing Date
Form Description
Form Type
2025-12-02
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-02 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-01
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-01 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-10
Belite Bio, Inc (BLTE) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-10 · Earnings Call
Belite Bio, Inc (BLTE) Q3 2025 Earnings Call Transcript
2025-11-10
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-11-10 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-22
Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
2025-10-22 ·
Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
2025-10-17
Form 144 - Report of proposed sale of securities
Ownership
2025-10-17 · Ownership
Form 144 - Report of proposed sale of securities
